Not yet recruiting
Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial
NCT07840456
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck HNSCC, +10 more
- Locations
-
- Universitätslklinikum Würzburg Würzburg, Bavaria, Germany
- Universitätsmedizin Greifswald Greifswald, Mecklenburg-Vorpommern, Germany
- Uniklinik Köln Cologne, North Rhine-Westphalia, Germany
- Katholisches Krankenhaus Hagen Hagen, North Rhine-Westphalia, Germany